ad Search Results


99
TaKaRa pgadt7
Pgadt7, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pgadt7/product/TaKaRa
Average 99 stars, based on 1 article reviews
pgadt7 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

94
R&D Systems recombinant human adamts4
Recombinant Human Adamts4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human adamts4/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant human adamts4 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
R&D Systems mouse recombinant adam10
Mouse Recombinant Adam10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse recombinant adam10/product/R&D Systems
Average 94 stars, based on 1 article reviews
mouse recombinant adam10 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
R&D Systems adamts1
Adamts1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adamts1/product/R&D Systems
Average 93 stars, based on 1 article reviews
adamts1 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
R&D Systems adam10
FIG. 3. Cleavage of EGF ligand ectodomains. Ectodomains were prepared as described under “Experimental Procedures” and incubated in the presence and absence of recombinant human TACE (150 g/ml: AR, HB-EGF; 300 g/ml: BTC, EPR) for 0–24 h. pro-HB-EGFecto was also incubated with recombinant human <t>ADAM10</t> (150 g/ml) for 0–24 h. Reactions were stopped by the addition of SDS-PAGE sample buffer and analyzed by Western blot analysis using the HA and FLAG antibodies.
Adam10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adam10/product/R&D Systems
Average 93 stars, based on 1 article reviews
adam10 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
R&D Systems recombinant adamts13
Figure 6. The therapeutic effect of MHLQD could not be replicated in VWF inhibitor-treated mice. The mice were intraperitoneally injected with D−GalN and LPS to establish ACLF and ALF models. The <t>rADAMTS13</t> (200 ug/kg), a VWF clearer, was injected into mice 0.5 h after D−GalN/LPS treatment. MHLQD or PBS was orally administrated to mice 1.5 h before and 1.5 h after LPS/D−GalN injection. (A): The experimental design of ACLF mice. (B): The H&E staining of the liver and the liver function levels (ALT and AST) in ACLF mice (n = 5). Scale bar: 0.25 mm. (C): The TUNEL staining and p-MLKL staining in liver tissues of ACLF mice. Scale bar: 0.25 mm (D): The experimental design of ALF mice. (E): The H&E staining of the liver and the liver function levels (ALT and AST) in ALF mice (n = 5). Scale bar: 0.25 mm. (F): The TUNEL staining and p-MLKL staining in liver tissues of ALF mice. Scale bar: 0.25 mm. (G): The protein expression of Caspase 3 and P-MLKL/MLKL in liver tissues of ACLF and ALF mice. ns: no significant. Abbreviation: MHLQD: Ma-Huang-LianQiao- ChiXiaoDou decoction, VWF: von Willebrand factor, ACLF: acute-on-chronic liver failure, ALF: acute hepatic failure.
Recombinant Adamts13, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant adamts13/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant adamts13 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
R&D Systems recombinant mouse adamts1
Figure 6. The therapeutic effect of MHLQD could not be replicated in VWF inhibitor-treated mice. The mice were intraperitoneally injected with D−GalN and LPS to establish ACLF and ALF models. The <t>rADAMTS13</t> (200 ug/kg), a VWF clearer, was injected into mice 0.5 h after D−GalN/LPS treatment. MHLQD or PBS was orally administrated to mice 1.5 h before and 1.5 h after LPS/D−GalN injection. (A): The experimental design of ACLF mice. (B): The H&E staining of the liver and the liver function levels (ALT and AST) in ACLF mice (n = 5). Scale bar: 0.25 mm. (C): The TUNEL staining and p-MLKL staining in liver tissues of ACLF mice. Scale bar: 0.25 mm (D): The experimental design of ALF mice. (E): The H&E staining of the liver and the liver function levels (ALT and AST) in ALF mice (n = 5). Scale bar: 0.25 mm. (F): The TUNEL staining and p-MLKL staining in liver tissues of ALF mice. Scale bar: 0.25 mm. (G): The protein expression of Caspase 3 and P-MLKL/MLKL in liver tissues of ACLF and ALF mice. ns: no significant. Abbreviation: MHLQD: Ma-Huang-LianQiao- ChiXiaoDou decoction, VWF: von Willebrand factor, ACLF: acute-on-chronic liver failure, ALF: acute hepatic failure.
Recombinant Mouse Adamts1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse adamts1/product/R&D Systems
Average 90 stars, based on 1 article reviews
recombinant mouse adamts1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

93
R&D Systems adamts 4 digestion
Figure 6. The therapeutic effect of MHLQD could not be replicated in VWF inhibitor-treated mice. The mice were intraperitoneally injected with D−GalN and LPS to establish ACLF and ALF models. The <t>rADAMTS13</t> (200 ug/kg), a VWF clearer, was injected into mice 0.5 h after D−GalN/LPS treatment. MHLQD or PBS was orally administrated to mice 1.5 h before and 1.5 h after LPS/D−GalN injection. (A): The experimental design of ACLF mice. (B): The H&E staining of the liver and the liver function levels (ALT and AST) in ACLF mice (n = 5). Scale bar: 0.25 mm. (C): The TUNEL staining and p-MLKL staining in liver tissues of ACLF mice. Scale bar: 0.25 mm (D): The experimental design of ALF mice. (E): The H&E staining of the liver and the liver function levels (ALT and AST) in ALF mice (n = 5). Scale bar: 0.25 mm. (F): The TUNEL staining and p-MLKL staining in liver tissues of ALF mice. Scale bar: 0.25 mm. (G): The protein expression of Caspase 3 and P-MLKL/MLKL in liver tissues of ACLF and ALF mice. ns: no significant. Abbreviation: MHLQD: Ma-Huang-LianQiao- ChiXiaoDou decoction, VWF: von Willebrand factor, ACLF: acute-on-chronic liver failure, ALF: acute hepatic failure.
Adamts 4 Digestion, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adamts 4 digestion/product/R&D Systems
Average 93 stars, based on 1 article reviews
adamts 4 digestion - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
Proteintech rabbit cnot1 wb proteintech
Figure 6. The therapeutic effect of MHLQD could not be replicated in VWF inhibitor-treated mice. The mice were intraperitoneally injected with D−GalN and LPS to establish ACLF and ALF models. The <t>rADAMTS13</t> (200 ug/kg), a VWF clearer, was injected into mice 0.5 h after D−GalN/LPS treatment. MHLQD or PBS was orally administrated to mice 1.5 h before and 1.5 h after LPS/D−GalN injection. (A): The experimental design of ACLF mice. (B): The H&E staining of the liver and the liver function levels (ALT and AST) in ACLF mice (n = 5). Scale bar: 0.25 mm. (C): The TUNEL staining and p-MLKL staining in liver tissues of ACLF mice. Scale bar: 0.25 mm (D): The experimental design of ALF mice. (E): The H&E staining of the liver and the liver function levels (ALT and AST) in ALF mice (n = 5). Scale bar: 0.25 mm. (F): The TUNEL staining and p-MLKL staining in liver tissues of ALF mice. Scale bar: 0.25 mm. (G): The protein expression of Caspase 3 and P-MLKL/MLKL in liver tissues of ACLF and ALF mice. ns: no significant. Abbreviation: MHLQD: Ma-Huang-LianQiao- ChiXiaoDou decoction, VWF: von Willebrand factor, ACLF: acute-on-chronic liver failure, ALF: acute hepatic failure.
Rabbit Cnot1 Wb Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit cnot1 wb proteintech/product/Proteintech
Average 94 stars, based on 1 article reviews
rabbit cnot1 wb proteintech - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

91
TaKaRa gal4 bd monoclonal antibody
Figure 6. The therapeutic effect of MHLQD could not be replicated in VWF inhibitor-treated mice. The mice were intraperitoneally injected with D−GalN and LPS to establish ACLF and ALF models. The <t>rADAMTS13</t> (200 ug/kg), a VWF clearer, was injected into mice 0.5 h after D−GalN/LPS treatment. MHLQD or PBS was orally administrated to mice 1.5 h before and 1.5 h after LPS/D−GalN injection. (A): The experimental design of ACLF mice. (B): The H&E staining of the liver and the liver function levels (ALT and AST) in ACLF mice (n = 5). Scale bar: 0.25 mm. (C): The TUNEL staining and p-MLKL staining in liver tissues of ACLF mice. Scale bar: 0.25 mm (D): The experimental design of ALF mice. (E): The H&E staining of the liver and the liver function levels (ALT and AST) in ALF mice (n = 5). Scale bar: 0.25 mm. (F): The TUNEL staining and p-MLKL staining in liver tissues of ALF mice. Scale bar: 0.25 mm. (G): The protein expression of Caspase 3 and P-MLKL/MLKL in liver tissues of ACLF and ALF mice. ns: no significant. Abbreviation: MHLQD: Ma-Huang-LianQiao- ChiXiaoDou decoction, VWF: von Willebrand factor, ACLF: acute-on-chronic liver failure, ALF: acute hepatic failure.
Gal4 Bd Monoclonal Antibody, supplied by TaKaRa, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gal4 bd monoclonal antibody/product/TaKaRa
Average 91 stars, based on 1 article reviews
gal4 bd monoclonal antibody - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

94
R&D Systems adam12 polyhistidine tag his
Figure 6. The therapeutic effect of MHLQD could not be replicated in VWF inhibitor-treated mice. The mice were intraperitoneally injected with D−GalN and LPS to establish ACLF and ALF models. The <t>rADAMTS13</t> (200 ug/kg), a VWF clearer, was injected into mice 0.5 h after D−GalN/LPS treatment. MHLQD or PBS was orally administrated to mice 1.5 h before and 1.5 h after LPS/D−GalN injection. (A): The experimental design of ACLF mice. (B): The H&E staining of the liver and the liver function levels (ALT and AST) in ACLF mice (n = 5). Scale bar: 0.25 mm. (C): The TUNEL staining and p-MLKL staining in liver tissues of ACLF mice. Scale bar: 0.25 mm (D): The experimental design of ALF mice. (E): The H&E staining of the liver and the liver function levels (ALT and AST) in ALF mice (n = 5). Scale bar: 0.25 mm. (F): The TUNEL staining and p-MLKL staining in liver tissues of ALF mice. Scale bar: 0.25 mm. (G): The protein expression of Caspase 3 and P-MLKL/MLKL in liver tissues of ACLF and ALF mice. ns: no significant. Abbreviation: MHLQD: Ma-Huang-LianQiao- ChiXiaoDou decoction, VWF: von Willebrand factor, ACLF: acute-on-chronic liver failure, ALF: acute hepatic failure.
Adam12 Polyhistidine Tag His, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adam12 polyhistidine tag his/product/R&D Systems
Average 94 stars, based on 1 article reviews
adam12 polyhistidine tag his - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
R&D Systems human adenosine deaminase
Figure 6. The therapeutic effect of MHLQD could not be replicated in VWF inhibitor-treated mice. The mice were intraperitoneally injected with D−GalN and LPS to establish ACLF and ALF models. The <t>rADAMTS13</t> (200 ug/kg), a VWF clearer, was injected into mice 0.5 h after D−GalN/LPS treatment. MHLQD or PBS was orally administrated to mice 1.5 h before and 1.5 h after LPS/D−GalN injection. (A): The experimental design of ACLF mice. (B): The H&E staining of the liver and the liver function levels (ALT and AST) in ACLF mice (n = 5). Scale bar: 0.25 mm. (C): The TUNEL staining and p-MLKL staining in liver tissues of ACLF mice. Scale bar: 0.25 mm (D): The experimental design of ALF mice. (E): The H&E staining of the liver and the liver function levels (ALT and AST) in ALF mice (n = 5). Scale bar: 0.25 mm. (F): The TUNEL staining and p-MLKL staining in liver tissues of ALF mice. Scale bar: 0.25 mm. (G): The protein expression of Caspase 3 and P-MLKL/MLKL in liver tissues of ACLF and ALF mice. ns: no significant. Abbreviation: MHLQD: Ma-Huang-LianQiao- ChiXiaoDou decoction, VWF: von Willebrand factor, ACLF: acute-on-chronic liver failure, ALF: acute hepatic failure.
Human Adenosine Deaminase, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human adenosine deaminase/product/R&D Systems
Average 94 stars, based on 1 article reviews
human adenosine deaminase - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

Image Search Results


FIG. 3. Cleavage of EGF ligand ectodomains. Ectodomains were prepared as described under “Experimental Procedures” and incubated in the presence and absence of recombinant human TACE (150 g/ml: AR, HB-EGF; 300 g/ml: BTC, EPR) for 0–24 h. pro-HB-EGFecto was also incubated with recombinant human ADAM10 (150 g/ml) for 0–24 h. Reactions were stopped by the addition of SDS-PAGE sample buffer and analyzed by Western blot analysis using the HA and FLAG antibodies.

Journal: Journal of Biological Chemistry

Article Title: Selective Roles for Tumor Necrosis Factor α-converting Enzyme/ADAM17 in the Shedding of the Epidermal Growth Factor Receptor Ligand Family

doi: 10.1074/jbc.m312141200

Figure Lengend Snippet: FIG. 3. Cleavage of EGF ligand ectodomains. Ectodomains were prepared as described under “Experimental Procedures” and incubated in the presence and absence of recombinant human TACE (150 g/ml: AR, HB-EGF; 300 g/ml: BTC, EPR) for 0–24 h. pro-HB-EGFecto was also incubated with recombinant human ADAM10 (150 g/ml) for 0–24 h. Reactions were stopped by the addition of SDS-PAGE sample buffer and analyzed by Western blot analysis using the HA and FLAG antibodies.

Article Snippet: In Vitro Digests—Aliquots (1–10 g) of ectodomain proteins were incubated with 150–300 g/ml recombinant human TACE or ADAM9 or ADAM10 (R & D Systems) or 10 mM Tris, pH 8.0 (as indicated) (31), for 1 or 24 h. Reactions were stopped by adding SDS-PAGE sample buffer, and products were separated by SDS-PAGE, transferred to Immobilon polyvinylidene difluoride, and probed with the indicated antibodies.

Techniques: Incubation, Recombinant, SDS Page, Western Blot

Figure 6. The therapeutic effect of MHLQD could not be replicated in VWF inhibitor-treated mice. The mice were intraperitoneally injected with D−GalN and LPS to establish ACLF and ALF models. The rADAMTS13 (200 ug/kg), a VWF clearer, was injected into mice 0.5 h after D−GalN/LPS treatment. MHLQD or PBS was orally administrated to mice 1.5 h before and 1.5 h after LPS/D−GalN injection. (A): The experimental design of ACLF mice. (B): The H&E staining of the liver and the liver function levels (ALT and AST) in ACLF mice (n = 5). Scale bar: 0.25 mm. (C): The TUNEL staining and p-MLKL staining in liver tissues of ACLF mice. Scale bar: 0.25 mm (D): The experimental design of ALF mice. (E): The H&E staining of the liver and the liver function levels (ALT and AST) in ALF mice (n = 5). Scale bar: 0.25 mm. (F): The TUNEL staining and p-MLKL staining in liver tissues of ALF mice. Scale bar: 0.25 mm. (G): The protein expression of Caspase 3 and P-MLKL/MLKL in liver tissues of ACLF and ALF mice. ns: no significant. Abbreviation: MHLQD: Ma-Huang-LianQiao- ChiXiaoDou decoction, VWF: von Willebrand factor, ACLF: acute-on-chronic liver failure, ALF: acute hepatic failure.

Journal: Cells

Article Title: Ancient Herbal Formula Mahuang Lianqiao Chixiaodou Decoction Protects Acute and Acute-on-Chronic Liver Failure via Inhibiting von Willebrand Factor Signaling.

doi: 10.3390/cells11213368

Figure Lengend Snippet: Figure 6. The therapeutic effect of MHLQD could not be replicated in VWF inhibitor-treated mice. The mice were intraperitoneally injected with D−GalN and LPS to establish ACLF and ALF models. The rADAMTS13 (200 ug/kg), a VWF clearer, was injected into mice 0.5 h after D−GalN/LPS treatment. MHLQD or PBS was orally administrated to mice 1.5 h before and 1.5 h after LPS/D−GalN injection. (A): The experimental design of ACLF mice. (B): The H&E staining of the liver and the liver function levels (ALT and AST) in ACLF mice (n = 5). Scale bar: 0.25 mm. (C): The TUNEL staining and p-MLKL staining in liver tissues of ACLF mice. Scale bar: 0.25 mm (D): The experimental design of ALF mice. (E): The H&E staining of the liver and the liver function levels (ALT and AST) in ALF mice (n = 5). Scale bar: 0.25 mm. (F): The TUNEL staining and p-MLKL staining in liver tissues of ALF mice. Scale bar: 0.25 mm. (G): The protein expression of Caspase 3 and P-MLKL/MLKL in liver tissues of ACLF and ALF mice. ns: no significant. Abbreviation: MHLQD: Ma-Huang-LianQiao- ChiXiaoDou decoction, VWF: von Willebrand factor, ACLF: acute-on-chronic liver failure, ALF: acute hepatic failure.

Article Snippet: The following chemicals were used: LPS (L2630, Sigma-Aldrich, St. Louis, MO, USA); D−GalN (MB1931, Meilunbio, Dalian, China); CCl4 (C805329, Macklin, Shanghai, China); Recombinant ADAMTS13 (4245-AD, R&D systems, Minneapolis, MN, USA).

Techniques: Injection, Staining, TUNEL Assay, Expressing